AVROBIO (AVRO) Financials

$1.45

$-15.59 (-91.49%)

As on 20-Jun-2024 17:53EDT

Market cap

$5 Mln

Revenue (TTM)

$4 Mln

P/E Ratio

0.2

P/B Ratio

0.6

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Operating Revenue	3.60	--	--	--	--	--
Cost of Revenue	2.68	0.62	4.17	1.40	1.21	0.85
Gross Profit	0.92	-0.62	-4.17	-1.40	-1.21	-0.85
Operating Expenses	54.06	71.05	105.43	118.84	120.23	75.81
Operating Profit (EBIT)	27.83	-71.67	-105.43	-118.84	-120.23	-75.81
Other Income	--	--	-0.46	--	0.52	2.84
Profit before Tax	30.68	12.53	-105.89	-119.13	-119.71	-72.97
Provision for Tax	-2.57	0.38	0.16	-1.40	-1.21	-0.85
Profit after Tax (Net Income)	30.31	12.16	-106.05	-117.73	-118.51	-72.12
Minority Interest	--	--	--	--	--	--
Consolidated Profit	67.48	--	-105.89	-119.13	-119.71	-72.97

Liabilities ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Shareholder's Funds	88.84	94.74	75.37	169.48	254.34	186.01
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	--	16.46	14.98	0.28	0.48
Current Liabilities	3.51	6.35	12.12	19.39	16.61	14.02
Total Liabilities	95.86	101.09	103.95	203.84	271.23	200.51

Assets ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Non-Current Assets	0.51	0.83	4.27	4.69	3.99	4.81
Current Assets	91.84	100.26	99.68	199.15	267.24	195.70
Total Assets	95.86	101.09	103.95	203.84	271.23	200.51
Total Debt*	0.22	0.88	17.46	14.95	--	--
Net Current Assets	88.33	93.91	86.84	179.76	250.63	181.68

Cashflow ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Cash From Operating Activities	--	-63.19	-97.21	-98.03	-98.80	-67.67
Cash Flow from Investing Activities	--	--	-0.27	-2.46	-1.18	-1.59
Cash from Financing Activities	--	-16.03	0.26	30.37	172.62	129.99
Net Cash Inflow / Outflow	--	--	-97.21	--	72.64	60.74

Financials Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Adjusted EPS ($)	--	--	--	--	--	--
Cash EPS ($)	--	--	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	--	--
Free Cash Flow per Share ($)	--	--	--	--	--	--

Profitability Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
ROCE (%)	--	12.90	-76.50	-53.66	-53.82	-46.80
ROE (%)	31.62	14.29	-86.62	-55.56	-53.82	-46.80
ROA (%)	31.81	11.86	-68.91	-49.56	-50.24	-43.18
EBIT Margin (%)	-1,439.53	--	--	--	--	--
Net Margin (%)	842.30	--	23,255.92	--	-22,966.09	-2,535.69
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	49.17	32.03	11.28	1.15	-58.59	-63.94
Net Profit Growth (%)	170.93	111.46	9.92	0.66	-64.33	-55.55
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Price / Earnings	0.17	--	--	--	--	--
Price / Book Value	0.60	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.57	1.37	0.72	1.49	2.18	2.50
Close Price ($)	15.36	16.32	8.55	46.20	167.28	241.56
High Price ($)	20.40	23.16	49.80	240.84	351.84	342.24
Low Price ($)	6.84	6.84	6.72	37.98	117.12	142.14
Market Cap ($ Cr)	5.24	--	--	--	--	--

Solvency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debt to Equity	--	0.01	0.23	0.09	--	--
Short term debt to equity ratio	0.00	0.01	0.01	--	--	--
Current Ratio	26.17	15.78	8.23	10.27	16.09	13.96
Quick Ratio	26.17	--	8.25	10.41	16.24	14.11
Interest Coverage	15.13	-29.61	-352.62	-530.54	-167.22	--

Operating Efficiency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	0.04	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	-159.24	-130.02	-686.51	-711.44	-791.73
Payable days	--	121.65	169.65	805.17	1,003.30	1,446.60
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.